Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) announced that it has received notice that, effective following the close of trading on December ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE